Latest Insights & Research

Stay informed with the latest public health research, insights, and evidence-based analysis from our team of experts.

Policy

The Trump Administration’s 2025 Drug Policy Priorities: A Public Health Perspective

The recent unveiling of the Trump Administration’s drug policy priorities represents a pivotal moment in the fight against America’s escalating substance abuse crisis, particularly in relation to the opioid epidemic fueled by fentanyl. This comprehensive blueprint outlines ambitious strategies aimed at strengthening interdiction efforts, enhancing prevention initiatives, and expanding access to treatment. However, a closer […]

Read more →
Mental health

The Power of Peer Support in Overdose Prevention

In the ongoing battle against the overdose crisis, a powerful ally has emerged: peer support. A recent comprehensive review highlights the pivotal role of individuals with lived experience in overdose prevention interventions. By leveraging their unique insights and experiences, peers are not only saving lives but also transforming the way we approach harm reduction. The […]

Read more →
Mental health

The Overdose Crisis: A Personal Perspective

In the United States, the devastating impact of drug overdose is a stark reality for millions. Since 1999, over a million lives have been lost to drug overdose, and the ripple effects of these tragedies extend far beyond the individuals who succumb to addiction. This blog explores a recent study that reveals the personal toll […]

Read more →
Mental health

Kratom: A Potential Ally in Overdose Prevention

The struggle with substance use disorders (SUDs) continues to plague many individuals, bringing with it a host of physical, emotional, and societal challenges. In the search for effective harm-reduction strategies, a unique herbal substance known as kratom has emerged, sparking both hope and controversy. Could kratom be a valuable tool in preventing overdoses and supporting […]

Read more →

Get the public-health insights you need—
every Thursday morning.

We scan 70+ journals so you don't have to.
One email. Zero jargon. Unsubscribe anytime.

🔒 No spam. 1-click opt-out. Privacy-first.